I. J. of Business & Management Research
Research Article | 
The Antibiotic Resistance Crisis - An Indian Perspective
Author(s) : Saini Devanshi and Dr. B. Lakshmi
Publisher : FOREX Publication
Published : 30 December 2020
e-ISSN : 2347-4696
Page(s) : 112-116
Abstract
This research study reiterates the optimal usage of antimicrobial medicines in humans and animals to lessen antibiotic resistance. A primary survey was conducted to study an individual’s role in prevention and control of antibiotic resistance. It was found that antibiotics are being irrationally used and the efficacy of antibiotics, as previously transforming the medical sciences and saving lives of many is in danger due to the quick emergence of bacterial resistance. Extensive efforts are therefore required to manage crisis by implementing new policies and renewing research efforts. Additionally, there exists a dire need to educate patients and public regarding antibiotic resistance crisis.
Keywords: Antibiotics , Antibiotic resistance crisis , Anti-microbial resistance (AMR), multidrug resistance (MDR) , infection prevention and control (IPC).
Saini Devanshi , Department of Pharmaceutical Management, NIPER Hyderabad, Hyderabad, Telangana, India
Dr. B. Lakshmi, Department of Pharmaceutical Management, NIPER Hyderabad, Hyderabad, Telangana, India, Email: lakshmi.niperhyd@gov.in
[1] Ventola C. L. (2015). The antibiotic resistance crisis: part 1: causes and threats. P & T : a peer-reviewed journal for formulary management, 40(4), 277–283.
[2] Zaman, S. B., Hussain, M. A., Nye, R., Mehta, V., Mamun, K. T., & Hossain, N. (2017). A Review on Antibiotic Resistance: Alarm Bells are Ringing. Cureus, 9(6), e1403.
[3] Lushniak BD. Antibiotic resistance: a public health crisis. Public Health Rep. 2014;129(4):314–316.
[4] Luyt, C., Bréchot, N., Trouillet, J. et al. Antibiotic stewardship in the intensive care unit. Crit Care 18, 480 (2014). https://doi.org/10.1186/s13054-014-0480-6
[5] Michael CA, Dominey-Howes D, Labbate M. The antibiotic resistance crisis: causes, consequences, and management. Front Public Health. 2014; 2:145.
[6] Golkar Z, Bagazra O, Pace DG. Bacteriophage therapy: a potential solution for the antibiotic resistance crisis. J Infect Dev Ctries. 2014;8(2):129–136. 13.
[7] Centers for Disease Control and Prevention, Office of Infectious Disease Antibiotic resistance threats in the United States, 2013. Apr, 2013.
[8] Bartlett JG, Gilbert DN, Spellberg B. Seven ways to preserve the miracle of antibiotics. Clin Infect Dis. 2013;56(10):1445–1450.
[9] P. Courvalin and J. Davies, Antimicrobials: time to act!, Curr. Opin. Microbiol. 6 (2003), 425–426.
[10] O.A. Phillips, Antibacterial agents: patent highlights January to June 2003, Curr. Opin. Investig. Drugs 4 (2003), 926–936.
[11] Gould IM, Bal AM. New antibiotic agents in the pipeline and how they can overcome microbial resistance. Virulence. 2013;4(2):185–191.
[12] Piddock LJ. The crisis of no new antibiotics—what is the way forward? Lancet Infect Dis. 2012;12(3):249–253.
Saini Devanshi and Dr. B. Lakshmi (2020), The Antibiotic Resistance Crisis - An Indian Perspective. IJBMR 8(4), 112-116. DOI: 10.37391/IJBMR.080404.